A Comparative Oncology Study of Iniparib Defines Its Pharmacokinetic Profile and Biological Activity in a Naturally-Occurring Canine Cancer Model

• Corey Saba,

  Affiliation College of Veterinary Medicine, University of Georgia, Athens, Georgia, United States of America

  ⨯
• Melissa Paoloni,

  Affiliation Comparative Oncology Program, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, United States of America

  ⨯
• Christina Mazcko,

  Affiliation Comparative Oncology Program, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, United States of America

  ⨯
• William Kisseberth,

  Affiliation College of Veterinary Medicine, The Ohio State University, Columbus, Ohio, United States of America

  ⨯
• Jenna H. Burton,

  Affiliation College of Veterinary Medicine and Biological Sciences, Colorado State University, Fort Collins, Colorado, United States of America

  ⨯
• Annette Smith,

  Affiliation College of Veterinary Medicine, Auburn University, Auburn, Alabama, United States of America

  ⨯
• Heather Wilson-Robles,

  Affiliation College of Veterinary Medicine, Texas A&M University, College Station, Texas, United States of America

  ⨯
• Sara Allstadt,

  Affiliation School of Veterinary Medicine, University of California Davis, Davis, California, United States of America

  ⨯
• David Vail,

  Affiliation School of Veterinary Medicine, University of Wisconsin-Madison, Madison, Wisconsin, United States of America

  ⨯
• Carolyn Henry,

  Affiliation College of Veterinary Medicine, University of Missouri-Columbia, Columbia, Missouri, United States of America

  ⨯
• Susan Lana,

  Affiliation College of Veterinary Medicine and Biological Sciences, Colorado State University, Fort Collins, Colorado, United States of America

  ⨯
• E. J. Ehrhart,

  Affiliation College of Veterinary Medicine and Biological Sciences, Colorado State University, Fort Collins, Colorado, United States of America

  ⨯
• Brad Charles,

  Affiliation College of Veterinary Medicine and Biological Sciences, Colorado State University, Fort Collins, Colorado, United States of America

  ⨯
• Michael Kent,

  Affiliation School of Veterinary Medicine, University of California Davis, Davis, California, United States of America

  ⨯
• Jessica Lawrence,

  Affiliation College of Veterinary Medicine, University of Georgia, Athens, Georgia, United States of America

  ⨯
• Kristine Burgess,

  Affiliation School of Veterinary Medicine, Tufts University, North Grafton, Massachusetts, United States of America

  ⨯
• Antonella Borgatti,

  Affiliation College of Veterinary Medicine, University of Minnesota, St. Paul, Minnesota, United States of America

  ⨯
• Steve Suter,

  Affiliation College of Veterinary Medicine, North Carolina State University, Raleigh, North Carolina, United States of America

  ⨯
• Paul Woods,

  Affiliation Ontario Veterinary College, University of Guelph, Guelph, Ontario, Canada

  ⨯
• Ira Gordon,

  Affiliation Comparative Oncology Program, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, United States of America

  ⨯
• Patricia Vrignaud,

  Affiliation Sanofi Aventis, Guesde, Vitry-sur-Seine, 94403 Cedex, France

  ⨯
• Chand Khanna,

  Affiliation Comparative Oncology Program, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, United States of America

  ⨯
•  [ ... ],
• Amy K. LeBlanc

  * E-mail: amy.leblanc@nih.gov

  Affiliation Comparative Oncology Program, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, United States of America

  ⨯
• [ view all ]
• [ view less ]